Valuation: Lumiera Health Inc.

Capitalization 850K 731K 669K 632K 1.17M 82.08M 1.19M 7.93M 3.1M 38.75M 3.19M 3.12M 135M P/E ratio 2021
-1.52x
P/E ratio 2022 -0.31x
Enterprise value 2.73M 2.35M 2.15M 2.03M 3.75M 264M 3.81M 25.48M 9.97M 124M 10.25M 10.03M 434M EV / Sales 2021
5.51x
EV / Sales 2022 4.33x
Free-Float
49.56%
Yield 2021 *
-
Yield 2022 -
3 years 0
Extreme 0.005
0
5 years 0
Extreme 0.005
0.04
10 years 0
Extreme 0.005
0.43
Manager TitleAgeSince
Director of Finance/CFO 68 29/06/2023
Director TitleAgeSince
Chairman - 01/09/2020
Director/Board Member 68 18/11/2021
Director/Board Member - 22/02/2022
Change 5d. change 1-year change 3-years change Capi.($)
-.--%-.--%-.--%-.--% 992K
+1.46%+2.28%+42.03%+137.25% 909B
-0.13%-0.69%+49.63%+46.11% 552B
+0.40%+1.27%+17.41%+47.31% 375B
+0.35%+2.53%+24.56%+13.82% 332B
+0.08%+1.56%+33.00%+15.94% 291B
+0.67%+2.13%+27.09%+30.60% 287B
+1.12%+0.86%+48.60%-0.09% 279B
-1.62%-0.63%-37.76%-51.82% 199B
+1.17%-0.06%+23.84%+50.02% 179B
Average +0.35%-4.33%+22.84%+28.91% 340.31B
Weighted average by Cap. +0.57%+1.03%+31.73%+54.23%

Financials

2021 2022
Net sales 538K 463K 424K 400K 740K 51.98M 751K 5.02M 1.97M 24.54M 2.02M 1.98M 85.46M 631K 542K 496K 469K 867K 60.91M 881K 5.89M 2.3M 28.75M 2.37M 2.32M 100M
Net income -1.2M -1.03M -947K -895K -1.65M -116M -1.68M -11.23M -4.39M -54.87M -4.52M -4.42M -191M -2.77M -2.38M -2.18M -2.06M -3.81M -268M -3.87M -25.85M -10.12M -126M -10.4M -10.18M -440M
Net Debt 416K 358K 328K 310K 572K 40.23M 582K 3.89M 1.52M 18.99M 1.56M 1.53M 66.14M 1.88M 1.62M 1.48M 1.4M 2.58M 182M 2.63M 17.55M 6.87M 85.74M 7.06M 6.91M 299M
Logo Lumiera Health Inc.
Lumiera Health Inc. is a Canadian company that specializes in developing and commercializing consumer products for the natural health industry. Through its Holizen Laboratories division, the Company offers a diverse portfolio of herbal tonics and natural supplements, including a line of sleep aids. Additionally, the Company is introducing a topical product line that targets the endocannabinoid system without using cannabis, providing a solution for chronic pain and inflammation. Its brands also include Awaye and Bazzzics. Awaye is a topical product that works with the body's own endocannibinoid pain defense system and provides relief from both acute and chronic pain. Part of the Holizen portfolio, Bazzzics is a line of three formulas composed of sedative plant extracts that can be combined to address the customer's specific sleeping needs: pre-sleep serenity, fall asleep, and stay asleep.
Employees
-